Scientists engineer DNA-based nanotechnology to stimulate potent antitumor immune responses
| Date | 10th, Sep 2020 |
|---|---|
| Source | Nanowerk - Nanotechnology Websites |
DESCRIPTION
Synthetic DNA nanovaccines enhance killer T cell immunity resulting in tumor control in preclinical studies.